Daniel Yerace
Founder bij VININGS HOLDINGS INC.
Vermogen: 300 150 $ op 31-03-2024
Profiel
Daniel Yerace is the founder of Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. He is currently the Director & Vice President-Operations at Coeptis Therapeutics Holdings, Inc. Previously, he worked as a Senior Director-Global Supply Chain at Kadmon Pharmaceuticals LLC.
Yerace holds an undergraduate degree and an MBA from Waynesburg University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-03-2024 | 1 010 605 ( 2.80% ) | 300 150 $ | 31-03-2024 |
Actieve functies van Daniel Yerace
| Bedrijven | Functie | Begin |
|---|---|---|
| VININGS HOLDINGS INC. | Founder | - |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Chief Operating Officer | 28-10-2022 |
Coeptis Pharmaceuticals, Inc.
 Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Coeptis Pharmaceuticals, Inc. operates as a biopharmaceutical firm. It develops Consensi, a combination drug that is indicated for the treatment of osteoarthritis (OA) pain and hypertension. The company was founded by Dave Mehalick, Christine Sheehy, and Dan Yerace and is headquartered in Wexford, PA. | Founder | - |
Eerdere bekende functies van Daniel Yerace
| Bedrijven | Functie | Einde |
|---|---|---|
Kadmon Pharmaceuticals LLC
 Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Corporate Officer/Principal | - |
Opleiding van Daniel Yerace
| Waynesburg University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Coeptis Therapeutics, Inc.
 Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coeptis Therapeutics, Inc. is a pharmaceutical company focused on the development of therapeutics and technologies to disrupt conventional treatment paradigms. Its product portfolio includes CD38-GEAR-NK and a CD38-Diagnostic, which is focused on CD38-related cancers. The company was founded on February 15, 1996 and is headquartered in Wexford, PA. | Health Technology |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Health Technology |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Coeptis Pharmaceuticals, Inc. operates as a biopharmaceutical firm. It develops Consensi, a combination drug that is indicated for the treatment of osteoarthritis (OA) pain and hypertension. The company was founded by Dave Mehalick, Christine Sheehy, and Dan Yerace and is headquartered in Wexford, PA. | Health Technology |
| Coeptis Therapeutics Holdings, Inc. |
